ClinicalTrials.gg
RecruitingNCT07878078Updated Oct 16, 2026

Influence of Art Workshops and Cognitive Support for Families of Children With Cancer.

A Phase 3 interventional study of Art Workshops and Cognitive Support Sessions. in Psychologic Resilience, sponsored by Children's Cancer Hospital Egypt 57357. Recruiting at 1 site in Egypt. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Children's Cancer Hospital Egypt 57357 · Phase 3, Interventional, and Prevention

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Apr 2026, registered Sep 2026).
  • Started Apr 2026; still recruiting 5 months later.
Updated Oct 16, 2026Newly registeredGo to Updates ↓
Phase
Phase 3
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Study summary

This clinical trial aims to evaluate the effectiveness of combining art workshops and knowledge-based lectures in enhancing psychological resilience among parents of children with cancer, with the primary outcome focused on whether the integrated program improves resilience among parents of children with cancer and the secondary outcome examining whether the type of cancer (solid vs. hematological) influences results; participants will engage in a structured 3-month program consisting of 12 sessions delivered to a fixed group, each lasting two hours.

Read the detailed description

The goal of this clinical trial is to evaluate the effectiveness of combining art workshops and knowledge-based lectures in enhancing psychological resilience among parents of children with cancer.

Primary outcome: Does combining art workshops and knowledge-based lectures enhance psychological resilience among parents of children with cancer? Secondary outcome: Is the type of cancer either solid or hematological influences the effects of the resilience program? The sample will be selected randomly from parents of children with cancer.

Total sample size: 64 participants, divided into two groups:

Experimental group: 32 participants receiving the combined program (art workshops + knowledge lectures).

Control group: 32 participants receiving standard care without the intervention.

Allocation will be conducted using Block Stratified Randomization software version.

02

Conditions studied

  • Psychologic Resilience

Keywords

  • parents of children with cancer
  • psychological resilience
03

In context

Lead sponsor

Children's Cancer Hospital Egypt 57357 is the lead sponsor of 21 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Parents (mother or father) of children with cancer currently undergoing treatment.
  • Age between 20 and 60 years.
  • Willingness to cooperate and participate in the program.
  • Caregiver must be one of the parents

Exclusion criteria

Exclusion Criteria:

  • Cases with major depressive disorder, psychotic disorders (e.g., schizophrenia), bipolar disorder, recurrent panic disorder, or severe phobias.
  • Parents unable to commit to attending sessions or following the program schedule.
  • Cases with cognitive impairments or inability to communicate verbally.
  • Families whose child is receiving palliative care.
05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    Experimental

    32 participants will be exposed to the 12-session program over 3 months, each session lasting 2 hours with pre- and post program assessments.

    Behavioral: Art Workshops and Cognitive Support Sessions.

  • No intervention
    Control

    32 participants will only receive pre- and post assessments without intervention.

Interventions

  • BehavioralArt Workshops and Cognitive Support Sessions.

    A structured behavioral program designed for parents of children with cancer. The intervention consists of 12 group sessions delivered over 3 months, each lasting 2 hours. Sessions combine guided art activities and cognitive support lectures aimed at enhancing psychological resilience.

06

What researchers measure

Primary outcomes

  1. The Psychological Resilience Scale by Connor and Davidson (Davidson-Connor), adapted by Singh and Nan Yu (2010) and translated to Arabic by Ahmed Elbaiomy.

    The Connor-Davidson Resilience Scale (CD-RISC) defines resilience through several dimensions, each capturing a different psychological strength: hardiness, optimism, resourcefulness, and purpose/goal. Together, they measure how individuals adapt and thrive under stress. The scale consists of 25 items. Responses are given from the following options: * Very high degree * High degree * Moderate degree * Low degree * Very low degree Each item is scored from 5 points down to 1 point. The highest possible score is 125 (25 items × 5 points). The lowest possible score is 25 (25 items × 1 point). High scores indicate strong resilience, while low scores indicate weak resilience.

    Time frame: From enrollment to the end of the program at 3 months (total of 12 sessions)

Secondary outcomes

  1. The impact of art workshops and cognitive lectures for parents of children with solid tumors vs. liquid tumors by comparing the level of psychological resilience and coping ability in those parents.

    Using the Connor-Davidson Resilience Scale (CD-RISC) which defines resilience through several dimensions, each capturing a different psychological strength: hardiness, optimism, resourcefulness, and purpose/goal. Together, they measure how individuals adapt and thrive under stress. The scale consists of 25 items. Responses are given from the following options: Very high degree High degree Moderate degree Low degree Very low degree Each item is scored from 5 points down to 1 point. The highest possible score is 125 (25 items × 5 points). The lowest possible score is 25 (25 items × 1 point). High scores indicate strong resilience, while low scores indicate weak resilience. Results from parents of children with solid tumors and liquid tumors are compared to see the if there are any differences in the impact of these art workshops and cognitive lectures between the two populations.

    Time frame: From enrollment to the end of program at 3 months.

07

Study locations

1 of 1 sites recruiting
  • Children's cancer hospital 57357
    Cairo, Cairo Governorate 11617, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07878078
Lead sponsor
Children's Cancer Hospital Egypt 57357
Responsible party
Sponsor
First posted
Oct 16, 2026
Start date
Apr 27, 2026
Primary completion
Jan 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Oct 16, 2026

Study contacts

Nancy Ashraf Abdellatif
Contact
nancy.ashraf@57357.com
+201141083507
Amira Kaseem Elsahhar
principal investigator · Children's cancer hospital 57357
Heba Mohamed Atef
principal investigator · Children's cancer hospital 57357

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion